{{ $DoctorName }} @if (isset(session()->get('doctor')['vCentralCode'])) {{ session()->get('doctor')['vCentralCode'] }} @endif
@if (isset(session()->get('doctor')['vCentralCode']))
Logout
@endif

{{ $ActivityTypeName }}

{{ $ActivityName }}

@csrf
@if (isset(session()->get('doctor')['vCentralCode']))
Back
@else
@endif
  1. What % of your patients do you manage with non-SU based therapy? *

  2. Will you rank your reservations about SU therapy: *

  3. How strongly do you believe are the chances of secondary failure with SU in a long run? *

  4. What is the approximate time period you encounter generally for patients to reach secondary failure with SU therapy? *

  5. Generally do you believe in adding SU early vs. late in your patients? *

  6. Generally diabetes being a multifactorial disease do you believe targeting multiple pathophysiology's can offer better glycaemic *

  7. According to you initial usage of SU will be replaced by which class of drug? *

  8. On patients uncontrolled on Metformin which of the following class of drug would you like to initiate first? *

  9. What is the rationale for choosing fixed-dose combinations *

  10. In your 100 Diabetic patients what % of patients would you like to recommend below class of new OAD FDC? (Sum total of response should be 100) *
    11. SU + Metformin + DPP4i
    %
    SU + Metformin + SGLT2i
    %
    DPP4i + SGLT2i+ Metformin
    %
    Total 100%
  11. What according to you are the merits of FDC in diabetes treatment? (Choose any 2) *

  12. Amongst the FDCs of SGLT2i +DPP4i which of the following distinguishing parameter do you find most attractive (Choose 1) *

  13. In your 100 Diabetic patients what % of patients would you have on *